Prehypertension - time to act
- PMID: 22382212
Prehypertension - time to act
Abstract
The term "prehypertension" defined as systolic blood pressure between 120 and 139 mmHg and/or diastolic pressures between 80 and 89 mmHg has now gained general acceptance. Prehypertension is associated with ~3-fold greater likelihood of developing hypertension, and roughly twice the number of cardiovascular events, than BP < 120/80 mmHg. When compared with normotensive individuals, prehypertensive individuals are more likely to be overweight and obese, to have other cardiovascular risk factors, to progress to established hypertension, and to experience premature clinical cardiovascular disease. The major unresolved issue is the appropriate management of such patients. Lifestyle modification is recommended for all patients with prehypertension as it effectively reduces rate of cardiovascular events. Presently pharmacological therapy is indicated for some patients with prehypertension who have specific comorbidities, including diabetes mellitus, chronic kidney disease, and coronary artery disease.
Similar articles
-
Prehypertension: an opportunity for a new public health paradigm.Cardiol Clin. 2010 Nov;28(4):561-9. doi: 10.1016/j.ccl.2010.07.008. Cardiol Clin. 2010. PMID: 20937441 Review.
-
Prehypertension: the rationale for early drug therapy.Cardiovasc Ther. 2010 Dec;28(6):339-43. doi: 10.1111/j.1755-5922.2010.00167.x. Cardiovasc Ther. 2010. PMID: 20553286 Review.
-
Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences.Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1725-33. doi: 10.1586/14779072.2013.857272. Expert Rev Cardiovasc Ther. 2013. PMID: 24215200 Review.
-
Prehypertension.Nat Clin Pract Cardiovasc Med. 2007 Oct;4(10):538-48. doi: 10.1038/ncpcardio0989. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17893682 Review.
-
Prehypertension: should we be treating with pharmacologic therapy?Ther Adv Cardiovasc Dis. 2008 Aug;2(4):305-14. doi: 10.1177/1753944708094226. Ther Adv Cardiovasc Dis. 2008. PMID: 19124429 Review.
Cited by
-
Blood pressure and noncommunicable diseases in middle-aged and older adults in China.PLoS One. 2018 Nov 2;13(11):e0206635. doi: 10.1371/journal.pone.0206635. eCollection 2018. PLoS One. 2018. PMID: 30388163 Free PMC article.
-
Prehypertension and incidence of cardiovascular disease: a meta-analysis.BMC Med. 2013 Aug 2;11:177. doi: 10.1186/1741-7015-11-177. BMC Med. 2013. PMID: 23915102 Free PMC article.
-
The Association of the Metabolic Score for Insulin Resistance (METS-IR) with Prehypertension in Normoglycemic Individuals.Int J Endocrinol Metab. 2024 Aug 3;22(2):e145894. doi: 10.5812/ijem-145894. eCollection 2024 Apr. Int J Endocrinol Metab. 2024. PMID: 40071249 Free PMC article.
-
Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis.J Am Heart Assoc. 2015 Feb 19;4(2):e001519. doi: 10.1161/JAHA.114.001519. J Am Heart Assoc. 2015. PMID: 25699996 Free PMC article.
-
Impact of prehypertension on left ventricular mass and QT dispersion in adult black Nigerians.Cardiovasc J Afr. 2014 Mar-Apr;25(2):78-82. doi: 10.5830/CVJA-2014-010. Cardiovasc J Afr. 2014. PMID: 24844553 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical